To obtain help on using IRIS contact iris_support@ucl.ac.uk
For queries about the IRIS project please contact iris@ucl.ac.uk
IRIS FAQ (Frequently Asked Questions)
For queries about the IRIS project please contact iris@ucl.ac.uk
IRIS FAQ (Frequently Asked Questions)
Please report any queries concerning the funding data shown on the profile page to:
http://www.ucl.ac.uk/finance/secure/research/post_award
http://www.ucl.ac.uk/finance/secure/research/post_award
Please report any queries concerning the student data shown on the profile page to:
Email: studentrecords@ucl.ac.uk
Tel: 020 7679 7005 or 020 7679 7006 (Internal 37005 or 37006)
Email: studentrecords@ucl.ac.uk
Tel: 020 7679 7005 or 020 7679 7006 (Internal 37005 or 37006)

Browse IRIS
› More search options
Prof John Hardy
Department of Molecular Neuroscience
Queen Square House
Queen Square
London
WC1N 3BG
Tel: 020 3448 4722
Fax: 020 7833 1016
Appointment
- Chair of the Biology of Neurological Studies
- Molecular Neuroscience
- Institute of Neurology
- Faculty of Brain Sciences
Joined UCL
01/04/2007
Biography
John Hardy is the Chair of Molecular Biology of Neurological Disease at the UCL Institute of Neurology. With over 23,000 citations, Prof Hardy is the most cited Alzheimer's disease researcher in the UK (5th internationally). In recognition of his exceptional contributions to science, he was elected a Fellow of the Royal Society in 2009.
Research Groups
Research Themes
Research Summary
My research interests are in the genetic analysis of disease. Historically, we have worked on the genetic analysis of Alzheimer's disease and other dementias. More recently, we have worked on Parkinson's disease and other movement disorders and, most recently on motor neuron disease. Our early studies were on mendelian forms of disease and these studies continue, but an increasing focus has been on the genetic analysis of complex traits related to disease. Additionally, this latter analysis has made us increasingly interested in population genetics because the risk variants for human traits are likely to be different in different racial groups.
In all cases our intention is to develop an understanding of the underlying genetics of a disorder so we can work with those making cellular and animal models of the disease to help, both in the unerstanding of disease mechanisms and to help in the search for treatements. In this regard, we therefore have three types of collaborations: collaborations with clinicians who treat patients with disease, especially colleagues at the Institute of Neurology, but also elsewhere, collaborations with other geneticists to collaboratively analyse such patient material, and collaborations with cell biologists and transgenic mice people to eneble them to build good models of disease.
In all cases our intention is to develop an understanding of the underlying genetics of a disorder so we can work with those making cellular and animal models of the disease to help, both in the unerstanding of disease mechanisms and to help in the search for treatements. In this regard, we therefore have three types of collaborations: collaborations with clinicians who treat patients with disease, especially colleagues at the Institute of Neurology, but also elsewhere, collaborations with other geneticists to collaboratively analyse such patient material, and collaborations with cell biologists and transgenic mice people to eneble them to build good models of disease.
Academic Background
| 1981 | PhD | Doctor of Philosophy | Imperial College of Science, Technology and Medicine |
| 1976 | BSc | Bachelor of Science | University of Leeds |
